A new study led by researchers from VIB and KU Leuven shows that Parkinson's disease can be divided into distinct subtypes, ...

The universe is dead; long live the universe. Not right at this moment, not yet. But one day everything we know will be gone. The cities we build, the lakes we swim in, the planet we live on, the ...

In chemical processes for producing pharmaceuticals, catalysts are a core technology that determines production speed and cost. However, until now, there has been a trade-off between "precise but ...

Cyclic Materials is investing more than $82 million to establish a rare earth recycling campus in McBee, South Carolina. The new site, host to its second facility in the US, would have a processing ...

Toronto-based Cyclic Materials has announced the close of a $75 million Series C equity round—its largest to date—scaling up operations across the United States and Europe and accelerating its ...

Canada Growth Fund is investing US$25-million into Ontario rare-earths recycler Cyclic Materials Inc., the second early-stage, clean-technology, critical-minerals financing for CGF in just over a week ...

You can find over one million groups to join on LinkedIn, the social media network for professionals. Topics vary from discussions about how to think creatively to learning something new such as ...

The startup is poised to become a global leader in recycling rare earth magnets from old EVs, wind turbines, and more. Rare earth magnets are essential for clean energy, but only a tiny fraction of ...

Panelists discuss how emerging evidence from first-line therapy trials continues to demonstrate the superiority of quadruplet over triplet regimens, with the CEPHEUS subgroup analysis confirming that ...

When Sharisse Zeroonian experiences stress, anxiety or feels her period coming on, she might throw up as often as 15 times an hour — episodes of vomiting that could go on for days at a time. Then, she ...

TORONTO--(BUSINESS WIRE)--Cyclic Materials, the advanced recycling company building a circular supply chain for rare earth elements (REEs), today announced a USD $25 million investment to launch North ...

A phase 2 study using metronomic gemcitabine, doxorubicin, and docetaxel plus nivolumab in advanced leiomyosarcoma and liposarcoma (NCT04535713). The broad-spectrum KIT inhibitor NB003 and activity in ...